MarketCapExport financials
Wave Life Sciences Ltd. (WVE)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Wave Life Sciences Ltd. Income Statement 2025-2011 | WVE
Brief overview of income trends at Wave Life Sciences Ltd.
This overview is based on financial performance over the past five years. According to figures from Wave Life Sciences Ltd., revenue changed from $20.1 million to $42.7 million over five years. Overall revenue changed by +112.8%, equal to an annualized rate of about 16.3%. Revenue followed a strong upward trend without signs of stagnation.
The five-year EBITDA result moved by −47.8%: from −$143 million to −$212 million. The operating result developed less favorably than sales. At the operating-margin level, the figure shifted from −714.2% to −496%. The company improved its ability to convert sales into EBITDA.
The net financial result changed from −$150 million to −$204 million. The negative result deepened, showing weaker final efficiency.
Market value was $358 million at the start and $2.6 billion at the end. The higher valuation contrasts with weaker financial performance.
What the figures show
Positive developments coexist with areas of weakness. The constructive conclusion rests on positive operating leverage and a larger revenue base. The weaker side of the profile includes declining net profitability and a narrow EBITDA buffer. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Wave Life Sciences Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.6 B | 1.59 B | 649 M | 313 M | 113 M | 358 M | 242 B | 1.05 T | 1.06 T | 660 B | 142 B | - | - | - | - |
Shares |
169 M | 138 M | 106 M | 78.9 M | 51.8 M | 35.2 M | 33.9 B | 29 B | 26.5 B | 22.8 B | 10.5 B | - | - | - | - |
Historical Prices |
15.4 | 11.5 | 6.12 | 3.97 | 2.19 | 10.2 | 7.1 | 37.2 | 40 | 28.8 | 13.5 | - | - | - | - |
Net Income |
-204 M | -97 M | -57.5 M | -162 M | -122 M | -150 M | -194 M | -147 M | -102 M | -55.7 M | -19.2 M | -5.23 M | -3.32 M | - | - |
Revenue |
42.7 M | 108 M | 113 M | 3.65 M | 41 M | 20.1 M | 16 M | 14.4 M | 3.89 M | 1.09 M | 152 K | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 16 M | 14.4 M | 3.89 M | 1.09 M | 152 K | - | - | - | - |
Operating Income |
-215 M | -110 M | -68 M | -163 M | -127 M | -153 M | -208 M | -160 M | -102 M | -55.7 M | -19.3 M | -5.39 M | -3.57 M | - | - |
Interest Expense |
527 K | 3.23 M | 1.88 M | 7 K | 4.54 M | 2.06 M | 9.74 M | 9.55 M | -331 K | -50 K | 56 K | 261 K | 37 K | - | - |
EBITDA |
-212 M | -107 M | -63 M | -156 M | -120 M | -143 M | -201 M | -154 M | -100 M | -54.9 M | -18.7 M | -4.85 M | -3.3 M | - | - |
Operating Expenses |
258 M | 219 M | 181 M | 166 M | 168 M | 173 M | 224 M | 174 M | 106 M | 56.8 M | 19.4 M | - | - | - | - |
General and Administrative Expenses |
75.3 M | 59 M | 51.3 M | 50.5 M | 46.1 M | 42.5 M | 48.9 M | 39.5 M | 27 M | 16 M | 10.4 M | 3 M | 1.65 M | - | - |
All numbers in USD currency
Quarterly Income Statement Wave Life Sciences Ltd.
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
204 M | 200 M | 188 M | 168 M | 164 M | 163 M | 153 M | 133 M | 130 M | 129 M | 119 M | 106 M | 105 M | 102 M | 86.9 M | 93.9 M | 66.5 M | 60.5 M | 59.8 M | 50.7 M | 50 M | 49.1 M | 48.8 M | 38.4 M | 35.2 M | 34.5 M | 34.3 M | 34.3 M | 34.3 M | 32.6 M | 29.5 M | 29.3 M | 29.1 M | 27.9 M | 27.8 M | 27.8 M | 26.9 M | 23.5 M | 23.5 M | 23.4 M | 22.7 M | 21.6 M | 21.6 M | 9.22 M | 9.22 M | 8.27 M | 4.26 M | 4.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-69.4 M | -26.1 M | - | -53.9 M | -50.5 M | -46.9 M | - | -61.8 M | -32.9 M | -31.6 M | - | 7.25 M | -21.1 M | -27.4 M | - | -39 M | -41.3 M | -37.8 M | - | -6.23 M | -38.8 M | -42.5 M | - | -33.1 M | -40.5 M | -47.5 M | -56.8 M | -50.7 M | -41.9 M | -44.2 M | -37.9 M | -37.6 M | -35.9 M | -35.2 M | -30.8 M | -25.5 M | -24.6 M | -21.1 M | -18.5 M | -17.5 M | -11.6 M | -7.85 M | -7.1 M | -4.94 M | -3.7 M | -3.46 M | -1.75 M | -1.36 M | -1.72 M | -400 K | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
2.27 M | 38.2 M | - | - | 8.7 M | 9.18 M | - | - | 19.7 M | 12.5 M | - | 49.2 M | 22.1 M | 12.9 M | - | 285 K | 375 K | 1.75 M | - | 36.4 M | 2.78 M | - | - | 3.45 M | 3.03 M | 4.16 M | 2.4 M | 2.93 M | 7.63 M | 3.03 M | 3.62 M | 4.49 M | 4.88 M | 1.42 M | 1.68 M | 676 K | 676 K | 383 K | 676 K | 392 K | 417 K | - | - | 152 K | 126 K | 26 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-73.8 M | -31.3 M | - | -56.4 M | -52.8 M | -49.8 M | - | -63.9 M | -35 M | -34.5 M | - | 4.44 M | -23.5 M | -30.3 M | - | -38.9 M | -42.2 M | -38.1 M | - | -7.61 M | -39.8 M | -43.5 M | - | -34.4 M | -38.7 M | -50 M | -60.5 M | -54.2 M | -45.6 M | -48 M | -48.9 M | -38.2 M | -36.6 M | -35.8 M | -31.2 M | -26.4 M | -24.7 M | -20.2 M | -18.5 M | -17.2 M | -11.6 M | -7.95 M | -7.21 M | -4.99 M | -3.63 M | -3.46 M | - | -1.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-275 K | -80 K | - | 324 K | -82 K | 51 K | - | 337 K | -18 K | 365 K | - | 171 K | 118 K | 1.01 M | - | -701 K | 744 K | 254 K | - | 1.37 M | 1.05 M | 996 K | - | 1.29 M | -2 M | 2.11 M | - | 2.24 M | 2.12 M | 2.35 M | - | -468 K | -259 K | 343 K | - | -75 K | -64 K | -72 K | - | -36 K | 15 K | -4 K | - | 112 K | -7 K | 50 K | - | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-72.1 M | -30.5 M | - | - | - | -48.9 M | - | - | - | -33.4 M | - | - | - | -28.9 M | - | -33.8 M | -38.7 M | -36.4 M | - | -1.9 M | -36 M | -41.5 M | - | -28.3 M | -34.6 M | -48 M | -60.5 M | -48.6 M | -42 M | -46.2 M | -48.9 M | -34.4 M | -34.2 M | -34.6 M | -31.2 M | -25.1 M | -24 M | -19.9 M | -18.5 M | -16.7 M | -11.3 M | -7.8 M | -7.21 M | -4.71 M | -3.45 M | -3.38 M | - | -1.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
76.1 M | 69.5 M | - | 64 M | 61.5 M | 59 M | - | 56.2 M | 54.7 M | 47 M | - | 44.8 M | 45.6 M | 43.2 M | - | 39.2 M | 42.5 M | 39.8 M | - | 44 M | 42.6 M | 43.5 M | - | 37.9 M | 41.7 M | 54.2 M | 62.9 M | 57.1 M | 53.2 M | 51 M | 52.6 M | 42.7 M | 41.5 M | 37.2 M | 32.3 M | 27.7 M | 25.8 M | 20.6 M | 19.2 M | 17.6 M | 12.1 M | 7.95 M | 7.21 M | 4.99 M | 3.76 M | 3.49 M | 1.78 M | 1.35 M | 1.29 M | 968 K | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
24.8 M | 22.1 M | - | 18.1 M | 18 M | 18.4 M | - | 15 M | 14.3 M | 13.5 M | - | 13.1 M | 12.3 M | 12.2 M | - | 11.6 M | 12.8 M | 12.4 M | - | 12.9 M | 11 M | 10.1 M | - | 9.59 M | 10.2 M | 13 M | - | 12.5 M | 11.6 M | 10.9 M | - | 9.85 M | 8.9 M | 8 M | - | 7.57 M | 6.67 M | 5.85 M | - | 3.94 M | 3.65 M | 3.22 M | - | 2.86 M | 1.9 M | 1.88 M | - | 769 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Wave Life Sciences Ltd. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Schweiz
USA
Israel
China
Canada
Britain
Russia
